Markets

Meiwu Technology Extends Rally After AI Skincare Funding

Meiwu Technology shares jumped 97% Tuesday and rose 12% premarket after the company raised $15.65 million for an AI skincare platform.

Daniel Marsh · · · 2 min read · 3 views
Meiwu Technology Extends Rally After AI Skincare Funding
Mentioned in this article
WNW $3.12 -3.11%

Meiwu Technology Company Limited (WNW) saw its shares extend a dramatic rally in premarket trading Wednesday, following a nearly 100% surge in the prior session. The stock closed Tuesday at $4.75, up 97.10%, on heavy volume of approximately 51.9 million shares, and was quoted at $5.31, up 11.79%, before the opening bell.

Funding for AI Skincare Platform

The rally follows a May 8 SEC filing disclosing that Meiwu raised about $15.65 million through a private investment in public equity (PIPE) transaction. The company sold 25 million ordinary shares at $0.626 apiece to select investors. Proceeds are earmarked primarily for developing an artificial intelligence-powered skincare management platform, along with related digital infrastructure and working capital.

Recent Capital-Raising Activities

This latest financing comes on the heels of a $14 million registered direct offering in March, which involved the sale of 6,999,996 ordinary shares at $2.00 each along with one-year warrants. Additionally, the company executed a 1-for-100 reverse share split effective April 6, which consolidated shares and lifted the quoted price without altering underlying value.

Strategic Shift and Competitive Landscape

Meiwu, a British Virgin Islands holding company with operations in China, has been pivoting toward functional skincare after previous ventures in online food sales and messaging services. CEO Zhichao Yang has stated that AI tools could help manage complex datasets and streamline workflows. However, the company faces established competitors such as Perfect Corp., which already offers AI skin analysis and augmented reality tools to beauty brands.

Risks and Warnings

In its SEC filing, Meiwu warned that the skincare platform is still in early stages and may require significant spending. The company cautioned that the platform might not be developed, deployed, or monetized on time—or at all. It also flagged potential regulatory risks related to AI, healthcare, consumer protection, data privacy, and cybersecurity in China, the U.S., and the EU.

Market Outlook

Investors will watch Wednesday's regular session to gauge whether the premarket momentum holds. With Memorial Day approaching on May 25, the immediate trading activity will test if this rally reflects a financing-backed strategy shift or speculative buying in a microcap stock.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →